RPR Result

Sample type: Serum

Other names: syphilis

Non-Reactive
A non-reactive result on the Rapid Plasma Reagin (RPR) test suggests that there are no detectable reagin antibodies in the blood that are typically associated with syphilis. This result generally indicates that the individual does not have an active syphilis infection, provided the testing is done outside of the disease's window period (the time between initial infection and when the test can reliably detect antibodies). However, it's important to consider the timing of the test, as a very early infection might not yet have produced a detectable level of antibodies. Additionally, in late-stage syphilis, the RPR test can sometimes yield a non-reactive result. Therefore, if syphilis is strongly suspected based on symptoms or exposure history, further testing or retesting at a later date may be necessary for accurate diagnosis.
Reactive
A reactive result on the Rapid Plasma Reagin (RPR) test typically indicates the presence of antibodies in the blood that are associated with syphilis, suggesting a current or past infection with the Treponema pallidum bacterium. However, a reactive RPR is not definitive for syphilis, as false positives can occur due to other conditions like autoimmune diseases, other infections, or pregnancy. Therefore, a reactive RPR result is usually followed by confirmatory treponemal testing, such as the Fluorescent Treponemal Antibody Absorption (FTA-ABS) test or the Treponema pallidum Particle Agglutination (TP-PA) test, to accurately diagnose syphilis. Additionally, a reactive RPR can be useful in monitoring the effectiveness of syphilis treatment, as titers typically decrease following successful therapy.

The marker "RPR (Rapid Plasma Reagin) Result" on a sexually transmitted disease (STD) test panel is a critical diagnostic tool for syphilis, a bacterial infection caused by Treponema pallidum. The RPR test is a non-treponemal serological screening used to detect the presence of reagin, an antibody-like substance produced in response to the cellular damage caused by the syphilis bacteria. The test measures the levels of these antibodies in the plasma by assessing the agglutination (clumping) of certain cardiolipin-lecithin-cholesterol particles mixed with the patient's serum or plasma.

The RPR test is particularly valued for its ability to screen for active syphilis infections, monitor the effectiveness of treatment, and in some cases, suggest re-infection or treatment failure. A positive RPR result often indicates an active syphilis infection but must be confirmed with specific treponemal tests, like the Fluorescent Treponemal Antibody Absorption (FTA-ABS) test or the Treponema pallidum Particle Agglutination (TP-PA) test, to differentiate it from other conditions that can cause a positive RPR, such as certain autoimmune diseases or other infections.

The RPR test's sensitivity varies depending on the stage of syphilis. It is most sensitive during secondary syphilis (around 98%) and less sensitive in the early and late stages of the disease. One of the limitations of the RPR test is the possibility of false positives and negatives. False-positive results can occur due to various conditions, including pregnancy, intravenous drug use, or certain viral infections like HIV. In contrast, false negatives might occur in early syphilis or the so-called "prozone phenomenon," where extremely high antibody levels interfere with the test's ability to detect them.

Regular screening for syphilis using the RPR test is crucial, particularly in sexually active individuals, as syphilis can be asymptomatic for long periods. Early detection and treatment are key to preventing serious health complications, such as cardiovascular and neurological damage, and to controlling its spread. The RPR test, despite its limitations, plays a pivotal role in public health strategies for the management and control of syphilis.

RPR Result
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond RPR Result — 10,000+ markers explained
One RPR Result result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro